NC
COLL icon

nVerses Capital’s Collegium Pharmaceutical COLL Stock Holding History

nVerses Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
+5,574
New +$190K 0.31% 193
2024
Q3 		– Sell
-1,700
Closed -$54.7K – 1066
2024
Q2 		$54.7K Buy
1,700
+1,600
+1,600% +$55.5K 0.03% 579
2024
Q1 		$3.88K Buy
+100
New +$3.5K 0.01% 600

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

nVerses Capital's COLL Position: Q2 2026 in Review

nVerses Capital opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 5,574 shares worth $202K. The stake represents 0.31% of the portfolio and ranks #193 among its holdings. This is a return to the name: nVerses Capital previously reported a position in COLL as recently as Q2 2024.

nVerses Capital first reported a position in COLL in Q1 2024 and has held it in 3 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • nVerses Capital held 5,574 shares of Collegium Pharmaceutical worth $202K as of Q2 2026.
  • Collegium Pharmaceutical was a new nVerses Capital position in Q2 2026.
  • Collegium Pharmaceutical made up 0.31% of nVerses Capital's portfolio in Q2 2026, its #193 holding.
  • nVerses Capital first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 3 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.